| ［1］ |
Santos G, Sousa L. Syndrome in question. Multiple autoimmune syndrome［J］. An Bras Dermatol, 2014, 89（2）: 361⁃362. DOI: 10. 1590/abd1806-4841.20142403.
|
| ［2］ |
Grandhe NP, Dogra S, Kanwar AJ. Multiple autoimmune syndrome in a patient with pemphigus vulgaris［J］. Acta Derm Venereol, 2005, 85（1）: 91⁃92. DOI: 10.1080/000155550410021691.
|
| ［3］ |
Khaled A, Fazaa B, Mrabet N, et al. Multiple autoimmune syndrome in a patient with pemphigus vulgaris: a new combination［J］. Tunis Med, 2008, 86（6）: 595⁃597.
|
| ［4］ |
Mohan MP, Ramesh TC. Multiple autoimmune syndrome［J］. Indian J Dermatol Venereol Leprol, 2003, 69（4）: 298⁃299.
|
| ［5］ |
McAllister WA, Thompson PJ, Al⁃Habet SM et al. Rifampicin reduces effectiveness and bioavailability of prednisolone［J］. Br Med J （Clin Res Ed）, 1983, 286（6369）: 923⁃925.
|
| ［6］ |
Van der Heyden S, Croubels S, Gadeyne C, et al. Influence of P⁃glycoprotein modulation on plasma concentrations and pharmacokinetics of orally administered prednisolone in dogs［J］. Am J Vet Res, 2012, 73（6）: 900⁃907. DOI: 10.2460/ajvr.73.6.900.
|
| ［7］ |
Naesens M, Kuypers DR, Streit F, et al. Rifampin induces alterations in mycophenolic acid glucuronidation and elimination: implications for drug exposure in renal allograft recipients［J］. Clin Pharmacol Ther, 2006, 80（5）: 509⁃521. DOI: 10.1016/j.clpt.2006.08.002.
|
